Abstract
HepatologyVolume 8, Issue 5 p. 1180-1180 CorrespondenceFree Access Hepatitis delta virus and primary hepatocellular carcinoma in jordan S. C. Arya MBBS, Ph.D., S. C. Arya MBBS, Ph.D. M-122 (of part 2) Greater Kailash-II, New Delhi 110048, IndiaSearch for more papers by this author S. C. Arya MBBS, Ph.D., S. C. Arya MBBS, Ph.D. M-122 (of part 2) Greater Kailash-II, New Delhi 110048, IndiaSearch for more papers by this author First published: September/October 1988 https://doi.org/10.1002/hep.1840080545AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Toukan AU, Abu-El-Rub OA, Abu-Laban SA, et al. The epidemiology and clinical outcome of hepatitis D virus (delta) infection in Jordan. Hepatology 1987; 7: 1340– 1345. 2 Ashraf SJ, Arya SC, Parande CM, et al. Antidelta antibody in primary hepatocellular carcinoma patients in the Gizan Area of Saudi Arabia. Infection 1986; 14: 250– 251. 3 Arya SC, Ashraf SJ, Parande CM, et al. Hepatitis B virus in Gizan, Saudi Arabia. J Med Virol 1985; 17: 267– 274. 4 Trichopoulos D, Day NE, Tzonou A, et al. Delta agent and the etiology of hepatocellular carcinoma. Int J Cancer 1987; 39: 283– 286. 5 Fagan E, Vergani D, Williams R. Delta hepatitis. Lancet 1987; 2: 1322– 1323. Volume8, Issue5September/October 1988Pages 1180-1180 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
